
NEXGEL, Inc.
NXGLNASDAQHealthcareMedical - Instruments & Supplies
最新資料
US$0.3631
+US$0.041 · +12.42%
NXGL公司概覽
盤中時間採用ET。市場資料可能有所延遲。
GoAI 研究快照
簡明呈現最新可用的模型資訊。
GoAI評分
Hold
Wait — insufficient conviction to act
估值
65
Undervalued
動能
21
Weakening
情緒
56
Mixed
風險韌性
31
High Risk
完整 GoAI 研究
繼續查看更深入的依據、催化因素和風險。
人工智慧產生的上下文僅供參考,並非投資建議。
公司概況
公司網站NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations. The company was founded in 1997 and operated under the name AquaMed Technologies, Inc. until it rebranded as NEXGEL, Inc. in November 2019. Its headquarters are located in Langhorne, Pennsylvania.
- 產業
- Medical - Instruments & Supplies
- 部門
- Healthcare
- 總部
- US
- 執行長
- Adam R. Levy
- 上市以來
- 2021年12月22日
- 僱員
- 19
市場位置
- 成交量
- 2439.84萬
- 71.03× 平均值
- 平均成交量
- 34.35萬
- 日均成交量
- 市值
- 314.45萬 USD
- 貝塔
- 0.77
- 市場參考 1
NXGL同業公司
繼續GoAI的研究
在 GoAI 中研究NXGLresearch.disclaimer





